The 10 Best Medical Procedures to Get in China as a UK Patient

China: £400–£600 · UK Private: £2,000–£3,500

This is the single best reason for a UK patient to fly to China. A full-body health MOT at a Grade-A hospital typically covers 40–70+ individual tests — blood panels (tumour markers, hormones, metabolic profile), ultrasound of every major organ, cardiac screening, lung function, and often a low-dose CT chest scan as standard.

In the UK, Bupa's top-tier "Health Assessment 360" covers roughly 30 biomarkers and costs £3,500. In China, you get twice the coverage for under £600 — including a senior physician consultation with English-language results. Most packages include same-day or next-day reporting.

Best for: Anyone over 40 who has not had a thorough check-up in years. Executives, frequent travellers, or anyone whose GP has told them "you are fine" without running anything beyond a basic blood test.

Why China wins: Volume. Chinese hospitals screen millions of patients per year through dedicated health-check centres. The process is industrialised — fast, comprehensive, and cheap — without sacrificing clinical quality.

China: £120–£250 per scan · UK Private: £400–£900

If you need an MRI or CT scan, China is one of the fastest and cheapest places on Earth to get one — with no compromise on image quality. Grade-A hospitals run 3T MRI machines from Siemens, GE, and Philips, identical to what the NHS uses.

The critical difference is speed. The NHS MRI waiting list averages 6–12 weeks from referral. In China, you can walk in and have the scan done the same day, with a radiologist's report before you leave the hospital.

Best for: Patients stuck on an NHS diagnostic waiting list who need answers now — particularly for musculoskeletal injuries, neurological symptoms, or suspected tumours.

Why China wins: Capacity. China has installed more MRI machines per capita than most developed nations in the last five years. There are no bottleneck queues.

China: £500–£700 per implant · UK Private: £1,900–£3,200

Dental implants in China are arguably the best value in world medical tourism right now — and it is not because of low wages. In 2023, the Chinese government launched a national Volume-Based Procurement (VBP) reform that slashed implant material costs by 50–80%. The same Straumann, Nobel Biocare, and Osstem implants used in London Harley Street clinics now cost a fraction of the price in Shanghai or Chengdu.

A single implant with crown in China typically costs £500–£700. A full-arch All-on-4 reconstruction runs £3,500–£5,500, versus £12,000–£17,000 in the UK.

Best for: UK patients needing multiple implants or full-arch work. The savings on two or more implants easily cover return flights and a week in China.

Why China wins: Government-mandated material cost reform. No other country has structurally reduced implant prices this aggressively.

China: £200–£600 · UK Private: £800–£2,000

Heart disease kills 170,000 people per year in the UK. Yet NHS cardiac screening waiting lists stretch to 4–8 months for an echocardiogram, and longer for a CT coronary angiography.

At a Grade-A hospital in China, a comprehensive cardiac package — resting ECG, echocardiogram, exercise stress test, CT coronary angiography, calcium score, and full cardiac blood panel — costs £200–£600 with results within 48 hours.

Best for: Adults over 50 with family history of heart disease, high-pressure professionals, or anyone with uncontrolled hypertension or elevated cholesterol who cannot get timely NHS investigation.

Why China wins: Integrated cardiology departments with same-day multi-modal investigation. No need to book separate appointments across different weeks and departments.

China: £3,000–£8,000 · UK Private: £8,000–£15,000+

HIFU was invented in China — specifically at Chongqing Medical University, which developed the first clinical HIFU device in the late 1990s. China has treated more HIFU patients than the rest of the world combined.

HIFU uses focused ultrasound beams to destroy tumours non-invasively — no incision, no radiation, minimal recovery. It is used for uterine fibroids, prostate tumours, liver and pancreatic cancers, and bone metastases. In the UK, HIFU availability is limited to a handful of specialist centres, with restricted NHS funding.

Best for: Patients diagnosed with uterine fibroids, early-stage prostate cancer, or certain liver tumours who want a non-invasive alternative to surgery. Patients whose NHS trust does not offer HIFU and who face a long referral pathway to a centre that does.

Why China wins: Origin country advantage. More cumulative clinical experience, more published data, lower cost, and wider availability than anywhere else.

China: £30,000–£80,000 · UK/US: £280,000–£350,000+

CAR-T (chimeric antigen receptor T-cell) therapy is a revolutionary immunotherapy that reprogrammes a patient's own immune cells to attack specific cancers. In the UK and US, a single course of approved CAR-T therapy (Kymriah or Yescarta) costs £280,000–£350,000, and NHS access is heavily rationed via NICE technology appraisals.

China approved its first domestic CAR-T products in 2021 and has since become the world's most active CAR-T clinical trial market. Chinese-developed CAR-T therapies — targeting both established (CD19) and novel antigens — are available at a fraction of the Western price.

Best for: Patients with relapsed or refractory B-cell lymphoma, acute lymphoblastic leukaemia (ALL), or multiple myeloma who do not qualify for NHS-funded CAR-T or face prohibitive UK private costs.

Why China wins: Faster regulatory approval for new constructs, dramatically lower manufacturing costs, and the world's largest pipeline of next-generation CAR-T trials — including bispecific and allogeneic ("off-the-shelf") variants not yet available in Europe.

China: £150–£350 · UK Private: £700–£1,500

In the UK, most NHS endoscopies are performed under conscious sedation — you are awake, uncomfortable, and the experience is memorable for all the wrong reasons. The NHS endoscopy waiting list is also one of the longest in diagnostics, with many patients waiting 8–14 weeks from referral.

Chinese Grade-A hospitals routinely perform endoscopy under propofol general anaesthesia as standard — not as a premium upgrade. You are asleep throughout, the procedure takes 15–30 minutes, and you recover within an hour. Biopsies and polyp removal are included if clinically indicated.

Best for: Patients over 45 due for bowel cancer screening, anyone with persistent GI symptoms (reflux, bloating, altered bowel habits), or patients who have been avoiding an endoscopy because the NHS version is unpleasant.

Why China wins: General anaesthesia as default rather than exception, combined with very short wait times and costs 75% below UK private sector.

China: £20–£50 per session · UK: £50–£100 per session

This is not a medical tourism procedure in the conventional sense — it is an experience you literally cannot replicate outside China. Acupuncture and tuina (therapeutic massage) at a TCM hospital in China are practised by specialists who trained for five or more years in dedicated Traditional Chinese Medicine universities. These are not high-street wellness practitioners with a weekend certification.

TCM hospitals in cities like Chengdu, Hangzhou, and Guangzhou offer structured treatment programmes for chronic pain, migraine, insomnia, stress disorders, and post-surgical rehabilitation. Sessions are typically 60–90 minutes and can be booked in multi-day intensive courses.

Best for: Patients with chronic musculoskeletal pain, tension headaches, stress-related conditions, or anyone curious about TCM from its source. Pairs exceptionally well with a health screening trip.

Why China wins: The birthplace, the deepest expertise, and a fraction of what UK TCM practitioners charge — with clinical-grade facilities rather than high-street shopfronts.

China: £1,000–£2,000 · UK Private: £3,000–£5,500

LASIK and ICL surgery in China are performed at dedicated ophthalmology centres within Grade-A hospitals, using the same Zeiss VisuMax and Alcon platforms found in leading UK clinics. The difference is price — and surgeon volume.

Chinese refractive surgeons routinely perform 1,000+ procedures per year. A typical UK surgeon does 200–400. Higher volume correlates with better outcomes, fewer complications, and faster procedures.

Best for: UK patients considering LASIK or ICL who are put off by UK private costs of £3,000–£5,500, or who want a surgeon with very high procedural volume.

Why China wins: Cost savings of 50–65%, combined with surgeon volume that is difficult to match in the UK market. ICL (implantable collamer lens) surgery — the premium alternative to LASIK for high-prescription patients — is particularly well-priced in China.

China: £4,000–£8,000 · UK Private: £10,000–£18,000

China's top orthopaedic centres — particularly in Shanghai, Beijing, and Guangzhou — have invested heavily in robotic-assisted joint replacement surgery using systems like MAKO (Stryker) and ROSA (Zimmer Biomet). These systems enable sub-millimetre precision in implant positioning, which translates to better function and longer implant life.

For UK patients stuck on the NHS hip replacement waiting list (average 12–18 months) or the knee replacement queue, China offers a comprehensive orthopaedic pathway: initial assessment, advanced imaging (weight-bearing MRI, 3D CT), robotic-assisted surgery, and structured post-operative rehabilitation.

Best for: Patients waiting over 6 months for NHS joint replacement, or those who want robotic-assisted surgery that is not widely available on the NHS.

Why China wins: Robotic surgery platforms in Grade-A hospitals that many NHS trusts do not yet have, combined with costs 50–60% below UK private equivalents.